Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
AVBP ArriVent BioPharma
- 22.480
- +0.750+3.45%
Close Mar 11 16:00 ET
- 22.480
- 0.0000.00%
Post 16:00 ET
764.68MMarket Cap-9.41P/E (TTM)
22.560High21.440Low208.48KVolume21.730Open21.730Pre Close4.60MTurnover1.32%Turnover RatioLossP/E (Static)34.02MShares36.37052wk High2.97P/B356.06MFloat Cap14.35052wk Low--Dividend TTM15.84MShs Float36.370Historical High--Div YieldTTM5.15%Amplitude14.350Historical Low22.069Avg Price1Lot Size
ArriVent BioPharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -25.73%-70.21M | -8.31%-16.15M | -5.85%-16.35M | -121.79%-19.09M | -10.35%-18.63M | -27.99%-55.84M | 6.13%-14.91M | -55.57%-15.44M | -8.61M | -16.88M |
| Net income from continuing operations | -16.09%-80.49M | 2.64%-20.63M | -42.80%-20.56M | -1.42%-21.87M | -43.09%-17.42M | -87.86%-69.33M | -102.96%-21.19M | -22.37%-14.4M | ---21.57M | ---12.17M |
| Change In working capital | -43.89%7.07M | -40.80%3.53M | 366.53%3.35M | -84.16%2.02M | 62.34%-1.84M | 276.19%12.6M | 207.25%5.96M | -172.76%-1.26M | --12.77M | ---4.88M |
| -Change in prepaid assets | -84.86%1.46M | -64.66%1.43M | -86.35%298K | -95.83%246K | 79.30%-508K | 171.23%9.67M | 176.22%4.04M | 167.29%2.18M | --5.9M | ---2.45M |
| -Change in payables and accrued expense | 91.69%5.63M | 9.12%2.11M | 188.64%3.06M | -73.84%1.8M | 44.71%-1.34M | -54.23%2.94M | 850.97%1.93M | -169.45%-3.45M | --6.87M | ---2.42M |
| -Change in other current assets | 42.86%-20K | 97.14%-1K | --0 | -157.14%-18K | 66.67%-1K | -318.75%-35K | -3,600.00%-35K | 150.00%10K | ---7K | ---3K |
| -Change in other current liabilities | -108.00%-2K | -116.00%-4K | ---4K | ---4K | --10K | --25K | --25K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -25.73%-70.21M | -8.31%-16.15M | -5.85%-16.35M | -121.79%-19.09M | -10.35%-18.63M | -27.99%-55.84M | 6.13%-14.91M | -55.57%-15.44M | ---8.61M | ---16.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -192.47M | -869.86%-192.47M | 0 | 0 | 25M | 0 | ||||
| Net investment purchase and sale | ---192.47M | -869.86%-192.47M | --0 | ---- | ---- | --0 | --25M | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---192.47M | -869.86%-192.47M | --0 | ---- | ---- | --0 | --25M | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 335.34%186.58M | 105.20%55K | 151.40%531K | 1,915.00%363K | 312.80%185.63M | -74.75%42.86M | -100.96%-1.06M | -1.03M | -20K | 44.97M |
| Net common stock issuance | --185.95M | --0 | --0 | --319K | --185.63M | --0 | --0 | --0 | --0 | --0 |
| Net preferred stock issuance | --0 | --0 | --0 | --0 | --0 | -73.53%44.92M | --0 | --0 | ---24K | --44.94M |
| Proceeds from stock option exercised by employees | 78.25%631K | -80.70%55K | 1,261.54%531K | 1,000.00%44K | -96.15%1K | 2,260.00%354K | 1,800.00%285K | --39K | --4K | --26K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---2.41M | ---1.34M | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 335.34%186.58M | 105.20%55K | 151.40%531K | 1,915.00%363K | 312.80%185.63M | -74.75%42.86M | -100.96%-1.06M | ---1.03M | ---20K | --44.97M |
| Net cash flow | ||||||||||
| Beginning cash position | -7.95%150.39M | 100.10%282.86M | 89.23%298.67M | 65.78%317.39M | -7.95%150.39M | 338.23%163.37M | 103.28%141.36M | 98.62%157.83M | --191.46M | --163.37M |
| Current changes in cash | -486.12%-76.1M | -2,409.66%-208.56M | 4.01%-15.81M | 44.32%-18.72M | 494.57%167M | -110.30%-12.98M | -90.38%9.03M | -65.98%-16.48M | ---33.63M | --28.09M |
| End cash Position | -50.60%74.29M | -50.60%74.29M | 100.10%282.86M | 89.23%298.67M | 65.78%317.39M | -7.95%150.39M | -7.95%150.39M | 103.28%141.36M | --157.83M | --191.46M |
| Free cash flow | -25.73%-70.21M | -8.31%-16.15M | -5.85%-16.35M | -121.79%-19.09M | -10.35%-18.63M | -27.99%-55.84M | 6.13%-14.91M | -55.57%-15.44M | ---8.61M | ---16.88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |